1. Hallmarks of Cancer-Related Newly Prognostic Factors of Oral Squamous Cell Carcinoma.
    Tomonori Sasahira et al, 2018, Int J Mol Sci CrossRef
  2. Exosomes as a Communication Tool Between the Lymphatic System and Bladder Cancer
    Rebekah J. Park et al, 2018, Int Neurourol J CrossRef
  3. Selenium Species: Current Status and Potentials in Cancer Prevention and Therapy.
    Andy T. Y. Lau, 0 CrossRef
  4. Systematic assessment of the clinicopathological prognostic significance of tissue cytokine expression for lung adenocarcinoma based on integrative analysis of TCGA data
    Yuanmei Dong et al, 2019, Sci Rep CrossRef
  5. Synergistic Anti-Angiogenic Effects Using Peptide-Based Combinatorial Delivery of siRNAs Targeting VEGFA, VEGFR1, and Endoglin Genes
    Anna A. Egorova et al, 2019, Pharmaceutics CrossRef
  6. Anti-Cancer Effects of Pristimerin and the Mechanisms: A Critical Review
    Jia-jun Li et al, 2019, Front. Pharmacol. CrossRef
  7. Magnetofection of Green Fluorescent Protein Encoding DNA-Bearing Polyethyleneimine-Coated Superparamagnetic Iron Oxide Nanoparticles to Human Breast Cancer Cells
    Merve Zuvin et al, 2019, ACS Omega CrossRef
  8. Tumor progression-dependent angiogenesis in gastric cancer and its potential application.
    Hsi-Lung Hsieh et al, 2019, World J Gastrointest Oncol CrossRef
  9. Targeting Tumor Endothelial Cells with Nanoparticles
    null Sakurai et al, 2019, IJMS CrossRef
  10. Clinical example of long-term control of disseminated signet-ring cell carcinoma of the stomach against the background of chemotherapy of the second line of treatment in combination with bevacizumab
    T. A. Titova et al, 2019, Medicinskij sovet CrossRef
  11. Multikinase Inhibitor Treatment in Thyroid Cancer
    Ole Vincent Ancker et al, 2019, IJMS CrossRef
  12. Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment
    Raluca Ioana Teleanu et al, 2019, JCM CrossRef
  13. Cellular and Extracellular Components in Tumor Microenvironment and Their Application in Early Diagnosis of Cancers
    Rui Wei et al, 2020, Analytical Cellular Pathology CrossRef
  14. null
    Nathan K. P. Wong et al, 2020 CrossRef
  15. Characterization of iRGD-Ligand Modified Arginine-Histidine-Rich Peptides for Nucleic Acid Therapeutics Delivery to αvβ3 Integrin-Expressing Cancer Cells
    Anna Egorova et al, 2020, Pharmaceuticals CrossRef
  16. The Current Status of Gene Therapy for the Treatment of Cancer.
    Tafere Mulaw Belete, 2021, Biologics CrossRef
  17. Endoglin in the Spotlight to Treat Cancer
    Teresa González Muñoz et al, 2021, IJMS CrossRef
  18. Firearms-related skeletal muscle trauma: pathophysiology and novel approaches for regeneration
    Anselmo Moriscot et al, 2021, npj Regen Med CrossRef
  19. Anti-Angiogenic Therapy: Current Challenges and Future Perspectives
    Filipa Lopes-Coelho et al, 2021, IJMS CrossRef
  20. An updated patent review of VEGFR-2 inhibitors (2017-present)
    Thoraya A. Farghaly et al, 2021, Expert Opinion on Therapeutic Patents CrossRef
  21. Immunotherapy Using Oxygenated Water and Tumor-Derived Exosomes Potentiates Antitumor Immune Response and Attenuates Malignancy Tendency in Mice Model of Breast Cancer
    Nafiseh Pakravan et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
  22. The Emerging Roles of Pericytes in Modulating Tumor Microenvironment
    Ruipu Sun et al, 2021, Front. Cell Dev. Biol. CrossRef
  23. LncRNA MORT (ZNF667-AS1) in Cancer—Is There a Possible Role in Gynecological Malignancies?
    Riccardo Di Fiore et al, 2021, IJMS CrossRef
  24. Differences of Angiogenesis Factors in Tumor and Diabetes Mellitus
    Shidong Tan et al, 2021, DMSO CrossRef
  25. Novel Anti-Angiogenic and Anti-Tumour Activities of the N-Terminal Domain of NOEY2 via Binding to VEGFR-2 in Ovarian Cancer
    Seung Bae Rho et al, 2021, Biomolecules & Therapeutics CrossRef
  26. Nutraceuticals and Cancer: Potential for Natural Polyphenols
    Jessica Maiuolo et al, 2021, Nutrients CrossRef
  27. Recapitulating the Angiogenic Switch in a Hydrogel-Based 3D In Vitro Tumor-Stroma Model
    Claudia Kuehlbach et al, 2021, Bioengineering CrossRef
  28. Gene therapy: A promising approach for breast cancer treatment
    Niloufar Tavakoli Dastjerd et al, 2021, Cell Biochem Funct CrossRef
  29. Synergistic effect of baculovirus-mediated endostatin and angiostatin combined with gemcitabine in hepatocellular carcinoma
    Yonggan Ji et al, 2021, Biological & Pharmaceutical Bulletin CrossRef
  30. Network Pharmacology-Based Study on the Active Component and Mechanism of the Anti-Non-Invasive and Invasive Bladder Urothelial Carcinoma Effects of Zhuling Jisheng Decoction
    Chenyu Ma et al, 2021, Computational and Mathematical Methods in Medicine CrossRef
  31. Chemotherapy Combined With Recombinant Human Endostatin (Endostar) Significantly Improves the Progression-Free Survival of Stage IV Soft Tissue Sarcomas
    Zhichao Liao et al, 2022, Front. Oncol. CrossRef
  32. Opportunities and Challenges of Nanoparticles in Digestive Tumours as Anti-Angiogenic Therapies
    Zhengyang Yang et al, 2022, Front. Oncol. CrossRef
  33. Current Understanding of Exosomal MicroRNAs in Glioma Immune Regulation and Therapeutic Responses
    Jinwu Peng et al, 2022, Front. Immunol. CrossRef
  34. IL-1β promotes hypoxic vascular endothelial cell proliferation through the miR-24-3p/NKAP/NF-κB axis
    Jiangnan Huang et al, 2022 CrossRef
  35. Poly-L-Lysine–Lactobionic Acid-Capped Selenium Nanoparticles for Liver-Targeted Gene Delivery
    Shaigan Naidoo et al, 2022, IJMS CrossRef
  36. AAV-Vectored Expression of the Vascular Normalizing Agents 3TSR and Fc3TSR, and the Anti-Angiogenic Bevacizumab Extends Survival in a Murine Model of End-Stage Epithelial Ovarian Carcinoma
    Ashley A. Stegelmeier et al, 2022, Biomedicines CrossRef
  37. Review and Comparative Analysis of Machine Learning-based Predictors for Predicting and Analyzing Anti-angiogenic Peptides
    Phasit Charoenkwan et al, 2022, CMC CrossRef
  38. Recent Progress of Machine Learning in Gene Therapy
    Cassandra Hunt et al, 2022, CGT CrossRef
  39. null
    Jin Wang et al, 2022 CrossRef
  40. Research progress and clinical application prospects of miRNAs in oral cancer
    Long Xing et al, 2022, Mol Biol Rep CrossRef
  41. Novel Drugs with High Efficacy against Tumor Angiogenesis
    Shiyu Qi et al, 2022, IJMS CrossRef
  42. Regulation and Function of Matrix Metalloproteinase-13 in Cancer Progression and Metastasis.
    Lu-gang Yu, 0 CrossRef
  43. PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor?
    Alessio Rizzo et al, 2022, Cancers CrossRef
  44. Recent Perspectives on the Mechanism of Recurrence After Ablation of Hepatocellular Carcinoma: A Mini-Review
    Jianquan Yang et al, 2022, Front. Oncol. CrossRef
  45. Decoding the mechanism of vascular morphogenesis to explore future prospects in targeted tumor therapy
    Gayathri Venkatakrishnan et al, 2022, Med Oncol CrossRef
  46. Applying artificial intelligence technology to assist with breast cancer diagnosis and prognosis prediction
    Meredith A. Jones et al, 2022, Front. Oncol. CrossRef
  47. In vivo assessment of functional and morphological alterations in tumors under treatment using OCT-angiography combined with OCT-elastography
    Marina A. Sirotkina et al, 2020, Biomed. Opt. Express CrossRef
  48. LINC00958 Inhibits Autophagy of Bladder Cancer Cells via Sponge Adsorption of miR-625-5p to Promote Tumor Angiogenesis and Oxidative Stress
    Ying Xiao et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
  49. Immunotherapeutic progress and application of bispecific antibody in cancer
    Jingyue Kang et al, 2022, Front. Immunol. CrossRef
  50. Alkaloid Derivative (Z)-3β-Ethylamino-Pregn-17(20)-en Inhibits Triple-Negative Breast Cancer Metastasis and Angiogenesis by Targeting HSP90α
    Xin-Yao Liu et al, 2022, Molecules CrossRef
  51. Adenocarcinomas of the Lung and Neurotrophin System: A Review
    Alberto Ricci et al, 2022, Biomedicines CrossRef
  52. The Efficacy of Fosbretabulin Disodium Combined with Radiofrequency Ablation in Lung Cancer
    Jieli Kou et al, 2022, Radiation Research CrossRef
  53. null
    Thomson Alex et al, 2022 CrossRef
  54. Personalized functional profiling using ex-vivo patient-derived spheroids points out the potential of an antiangiogenic treatment in a patient with a metastatic lung atypical carcinoid
    Hichul Kim et al, 2022, Cancer Biology & Therapy CrossRef
  55. The prospect of tumor microenvironment-modulating therapeutical strategies
    Dirk Eulberg et al, 2022, Front. Oncol. CrossRef
  56. Antiangiogenic activity of the penicillin derivative TAP7f in melanoma
    Elizabeth Barrionuevo et al, 2023, J Mol Med CrossRef
  57. Endothelial miR-196b-5p regulates angiogenesis via the hypoxia/miR-196b-5p/HMGA2/HIF1α loop
    Ruizhe Ren et al, 2023, American Journal of Physiology-Cell Physiology CrossRef
  58. Menthol: An underestimated anticancer agent
    Yijia Zhao et al, 2023, Front. Pharmacol. CrossRef
  59. Phase I study of the VEGF/Ang-2 inhibitor BI 836880 alone or combined with the anti-programmed cell death protein-1 antibody ezabenlimab in Japanese patients with advanced solid tumors
    Noboru Yamamoto et al, 2023, Cancer Chemother Pharmacol CrossRef
  60. Chitosan Modification-Enhanced Silencing Effect of Ad5-shPDGF-D Vector in Breast Cancer Cell Line MDA-MB-231
    Ceyda Ekentok-Atıcı et al, 2023, CDD CrossRef
  61. Research trends and hotspots on the links between caveolin and cancer: bibliometric and visual analysis from 2003 to 2022
    Yaqian Tan et al, 2023, Front. Pharmacol. CrossRef
  62. USO DE SISTEMAS NANOESTRUTURADOS NO TRATAMENTO DO CÂNCER
    Jony Marques Geraldo et al, 2023, MPJ CrossRef
  63. Molecular modeling, dynamic simulation, and metabolic reactivity studies of quinazoline derivatives to investigate their anti-angiogenic potential by targeting wild EGFR wt and mutant EGFR T790M receptor tyrosine kinases
    Altaf Ahmad Shah et al, 2023, Journal of Biomolecular Structure and Dynamics CrossRef
  64. The inhibitory effect of apatinib on different small cell lung cancer cells and in lung cancer‐bearing mice and patients
    Mingtao Liu et al, 2024, Clinical Respiratory J CrossRef
  65. Challenges and Opportunities of Gene Therapy in Cancer
    Milky Mittal et al, 2024, OBM Genet CrossRef
  66. Targeting hypoxia signaling pathways in angiogenesis
    Sara Monaci et al, 2024, Front. Physiol. CrossRef
  67. Innovating Cancer Treatment Through Cell Cycle, Telomerase, Angiogenesis, and Metastasis
    Tooba Yousefi et al, 2024, DNA and Cell Biology CrossRef
  68. Cancer Immunotherapy with “Vascular-Immune” Crosstalk as Entry Point: Associated Mechanisms, Therapeutic Drugs and Nano-Delivery Systems
    Zhijie Jiang et al, 2024, IJN CrossRef
  69. Baculovirus-mediated endostatin and angiostatin activation of autophagy through the AMPK/AKT/mTOR pathway inhibits angiogenesis in hepatocellular carcinoma
    Tingting Wei et al, 2024 CrossRef
  70. The missing link between cancer stem cells and immunotherapy
    Lobna Safwat Ali et al, 2024, Current Medical Research and Opinion CrossRef
  71. Comprehensive Review on Bubbles: Synthesis, Modification, Characterization and Biomedical Applications
    Donald A. Fernandes, 2024, Bioconjugate Chem. CrossRef
  72. Advancements in current one-size-fits-all therapies compared to future treatment innovations for better improved chemotherapeutic outcomes: a step-toward personalized medicine
    Nadia M. Hamdy et al, 2024, Current Medical Research and Opinion CrossRef
  73. Recent Progress on Nanomedicine‐Mediated Repolarization of Tumor‐Associated Macrophages for Cancer Immunotherapy
    Jing‐Yang Zhang et al, 2024, WIREs Nanomed Nanobiotechnol CrossRef
  74. Active transfection of genetic materials using cyclodextrin-anchored nanovectors
    Amey Revdekar et al, 2024, Mater. Adv. CrossRef
  75. Pan‐Cancer Single‐Cell Transcriptomic Analysis Reveals Divergent Expression of Embryonic Proangiogenesis Gene Modules in Tumorigenesis
    Zeshuai Wang et al, 2024, Cancer Medicine CrossRef
  76. Analysis of the Effects of Bevacizumab Combined with Chemoradiotherapy on VEGF, bFGF, and Let-7 Levels in Non-Small Cell Lung Cancer and the Factors Influencing Therapeutic Efficacy: A Retrospective Cohort Study
    Xiang-Chong Luo et al, 2024, IJGM CrossRef
  77. The role of N6-methyladenosine modification in tumor angiogenesis
    Lifei Qin et al, 2024, Front. Oncol. CrossRef
  78. Integrating Ultrabright Polymer Dots and Stereo NIR‐II Imager for Assessing Anti‐Angiogenic Drugs in Oral Cancer Model
    Bo‐Han Huang et al, 2025, J Cellular Molecular Medi CrossRef